tradingkey.logo
搜尋

TherapeuticsMD Inc

TXMD
添加自選
2.160USD
-0.050-2.26%
收盤 07/01, 16:00美東報價延遲15分鐘
25.00M總市值
138.82本益比TTM

關於 TherapeuticsMD Inc 公司

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Inc簡介

公司代碼TXMD
公司名稱TherapeuticsMD Inc
上市日期Jan 31, 2001
CEOWalker (Marlan D)
員工數量1
證券類型Ordinary Share
年結日Jan 31
公司地址951 Yamato Road, Suite 220
城市BOCA RATON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33431
電話15619611900
網址https://www.therapeuticsmd.com/
公司代碼TXMD
上市日期Jan 31, 2001
CEOWalker (Marlan D)

TherapeuticsMD Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
141.13K
+47.82%
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--

常見問題

TherapeuticsMD Inc的前五大股東是誰?

TherapeuticsMD Inc的前五大股東如下:Mr. Marlan D. Walker, J.D.

有多少機構持有TherapeuticsMD Inc(TXMD)的股份?

截至2026Q1,共有87家機構持有TherapeuticsMD Inc的股份,合計持有的股份價值約為3.82M,占公司總股份的32.99% 。與2025Q4相比,機構持股有所增加,增幅為423750.00。